Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Naftifine Hydrochloride Cream 2% vs Naftin® in Tinea Pedis
NCT02132260Phase 1Completed
- Start
- Aug 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of naftifine organogel (MediQuest Therapeutics) in tinea pedis (3 arms). Primary endpoint: Therapeutic Cure at 6 weeks. Started Aug 2013; status: completed.
02
Drugs
naftifine organogel (MediQuest Therapeutics)
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT02132260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132260.